methylprednisolone has been researched along with Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandão-Neto, RA; Ramos, RG; Santana, AN; Zanandrea, EF | 1 |
Aguilar, JL; Avalos-Díaz, E; González, I; Herrera-Esparza, R; López-Robles, E; Saucedo, A | 1 |
2 other study(ies) available for methylprednisolone and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia
Article | Year |
---|---|
Bone marrow necrosis successfully treated with corticosteroid.
Topics: Adrenal Cortex Hormones; Bone Marrow; CREST Syndrome; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Methylprednisolone; Middle Aged; Necrosis; Prednisone | 2005 |
Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
Topics: Antibodies, Antineutrophil Cytoplasmic; Biopsy, Needle; CREST Syndrome; Cyclophosphamide; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Methylprednisolone; Middle Aged; Peroxidase; Risk Assessment; Scleroderma, Systemic; Severity of Illness Index; Treatment Outcome | 2005 |